Amgen, Inc. (AMGN) Option Bulls Eye Higher Highs

Amgen, Inc.'s post-earnings rally is being cheered by yesterday's call buyers

Digital Content Group
Oct 28, 2014 at 10:39 AM
facebook twitter linkedin


Amgen, Inc. (NASDAQ:AMGN) hit a record high of $148.47 yesterday, prior to announcing earnings after the close. The strong price action lured plenty of options traders to the table, as volume more than doubled the expected single-session norm.

Most active was the biopharmaceutical firm's January 2015 155-strike call, where 1,870 contracts changed hands. More than 80% did so at the ask price, and open interest spiked overnight, indicating newly bought bullish bets. By purchasing the calls to open, the traders expected AMGN -- which settled at $148.20 on Monday -- to topple the strike by January 2015 options expiration.

As alluded to, the company reported earnings last night -- and the results were music to the ears of option bulls. In fact, AMGN has spiked nearly 5% to trade at $155.49, and earlier touched another all-time high of $155.80, after posting an earnings beat and upping its full-year outlook. The firm also announced a number of cost-cutting measures (including increased workforce reductions), as well as a stock buyback plan.

Not surprisingly, this news was met with applause on the Street, where AMGN received price-target hikes from no fewer than five brokerage firms. Most ambitious among them is Goldman Sachs, which upped its outlook by $10 to $175, to go along with its "buy" rating.

Returning once more to the January-dated options -- while they are currently at the money thanks to this morning's rally, the buyers need Amgen, Inc. (NASDAQ:AMGN) to climb even higher through options expiration. Based on the volume-weighted average price (VWAP) of $3.63, at-expiration breakeven for the calls is $158.63 (strike plus VWAP).

 

Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!